Skip to main content
The BMJ logoLink to The BMJ
. 2004 May 29;328(7451):0.

HRT increases unnecessary tests after breast cancer screening

PMCID: PMC420149

Useless tests after initial screening for breast cancer are more likely in women who are, or were, taking hormone replacement therapy. Banks and colleagues (p 1291) reviewed data from more than 87 000 postmenopausal women screened in the NHS, and found that 3% of those with a negative screening had subsequent tests. Tests (and biopsies) were more likely in women still taking hormone replacement therapy and in past users.


Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES